Decellularized Matrix Bioscaffolds: Implementation of Native Microenvironment in Pancreatic Tissue Engineering. Issue 7 (August 2021)

• Record Type: Journal Article
• Authors: Hashemi, Javad; Barati, Ghasem; Bibak, Bahram
• Is Part Of: Pancreas. Volume 50:Issue 7(2021)
• Page Start: 942
• Page End: 951
• Publication Date: 2021-08
• Subjects: pancreas bioengineering -- extracellular matrix -- stem cells -- decellularization -- regenerative medicine -- organ bioengineering -- ECM - extracellular matrix -- IPCs - insulin-producing cells -- MIN-6 - mouse insulinoma 6 -- MSCs - mesenchymal stem cells -- SDS - sodium dodecyl sulfate; Pancreas -- Diseases -- Periodicals; Pancreas -- Periodicals; Neuroendocrine tumors -- Periodicals; 616.37005
• DOI: 10.1097/MPA.0000000000001868
• Languages: English
• ISSNs: 0885-3177

Abstract

Abstract: Type 1 diabetes is an autoimmune disease, and its incidence is usually estimated in the range of 5% to 10%. Currently, the administration of exogenous insulin is the standard of care therapy. However, this therapy is not effective in some patients who may develop some chronic complications. Islet transplantation into the liver is another therapy with promising outcomes; however, the long-term efficacy of this therapeutic option is limited to a small number of patients. Because native extracellular matrix (ECM) components provide a suitable microenvironment for islet functions, engineering a 3-dimensional construct that recapitulates the native pancreatic environment could address these obstacles. Many attempts have been conducted to mimic an in vivo microenvironment to increase the survival of islets or islet-like clusters. With the advent of decellularization technology, it is possible to use a native ECM in organ engineering. Pancreatic decellularized bioscaffold provides proper cell-cell and cell-ECM interactions and retains growth factors that are critical in the determination of cell fate within a native organ. This review summarizes the current knowledge of decellularized matrix technology and addresses its possible limitations before use in the clinic.